198 related articles for article (PubMed ID: 23866030)
21. Decreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I-III gastric cancer.
Li G; Wang N; Sun C; Li B
World J Surg Oncol; 2014 Mar; 12():72. PubMed ID: 24678890
[TBL] [Abstract][Full Text] [Related]
22. High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend?
Rudno-Rudzinska J; Kielan W; Grzebieniak Z; Dziegiel P; Donizy P; Mazur G; Knakiewicz M; Frejlich E; Halon A
Gastric Cancer; 2013 Oct; 16(4):513-20. PubMed ID: 23238856
[TBL] [Abstract][Full Text] [Related]
23. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
[TBL] [Abstract][Full Text] [Related]
24. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
25. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Liu XY; Liu FY
World J Surg; 2011 Jan; 35(1):70-7. PubMed ID: 21046381
[TBL] [Abstract][Full Text] [Related]
26. High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.
Hu J; Xu Y; Shen ZZ; Wang Z; Lu Q; Yang GH; Ding ZB; Fan J; Zhou J
J Cancer Res Clin Oncol; 2009 Oct; 135(10):1359-67. PubMed ID: 19350273
[TBL] [Abstract][Full Text] [Related]
27. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
28. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.
Nakagawa M; Inokuchi M; Takagi Y; Kato K; Sugita H; Otsuki S; Kojima K; Uetake H; Sugihara K
Ann Surg Oncol; 2015 Jul; 22(7):2329-35. PubMed ID: 25391265
[TBL] [Abstract][Full Text] [Related]
30. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
31. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
32. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer.
Arigami T; Natsugoe S; Uenosono Y; Yanagita S; Ehi K; Arima H; Mataki Y; Nakajo A; Ishigami S; Aikou T
J Surg Oncol; 2009 Mar; 99(3):148-53. PubMed ID: 19117016
[TBL] [Abstract][Full Text] [Related]
34. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
Xie LX; Zhai TT; Yang LP; Yang E; Zhang XH; Chen JY; Zhang H
Int J Exp Pathol; 2013 Feb; 94(1):39-46. PubMed ID: 23317352
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma.
Takahashi K; Kaira K; Shimizu A; Sato T; Takahashi N; Ogawa H; Yoshinari D; Yokobori T; Asao T; Takeyoshi I; Oyama T
Tumour Biol; 2016 Oct; 37(10):13885-13892. PubMed ID: 27485115
[TBL] [Abstract][Full Text] [Related]
36. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer.
Matsumura S; Oue N; Mitani Y; Kitadai Y; Yasui W
Int J Cancer; 2007 Apr; 120(8):1689-95. PubMed ID: 17230534
[TBL] [Abstract][Full Text] [Related]
37. Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.
Park DJ; Seo AN; Yoon C; Ku GY; Coit DG; Strong VE; Suh YS; Lee HS; Yang HK; Kim HH; Yoon SS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1508-15. PubMed ID: 26259755
[TBL] [Abstract][Full Text] [Related]
38. Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.
Wang TB; Deng MH; Qiu WS; Dong WG
World J Gastroenterol; 2007 Mar; 13(12):1794-7; discussion 1797-8. PubMed ID: 17465468
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
Hepatogastroenterology; 2005; 52(62):629-32. PubMed ID: 15816493
[TBL] [Abstract][Full Text] [Related]
40. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.
Dinami R; Porru M; Amoreo CA; Sperduti I; Mottolese M; Buglioni S; Marinelli D; Maugeri-Saccà M; Sacconi A; Blandino G; Leonetti C; Di Rocco G; Verdina A; Spinella F; Fiorentino F; Ciliberto G; Biroccio A; Zizza P
J Exp Clin Cancer Res; 2020 Jun; 39(1):111. PubMed ID: 32539869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
